PPIDT00032
Drug Information
| Name | Interferon alfa-2a |
|---|---|
| Sequence | CDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE |
| DrugBank_ID | DB00034 |
| Type | biotech |
| Indication | For the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatment of oral warts arising from HIV infection. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Solution | Subcutaneous |
300000000000 IU
|
| Injection | Subcutaneous |
|
| Injection, solution | Intramuscular; Parenteral; Subcutaneous |
|
| Injection, solution | Parenteral; Subcutaneous |
|
| Injection, solution | Subcutaneous |
|
| Liquid | Intramuscular; Subcutaneous |
6000000 unit / mL
|
| Powder, for solution | Intramuscular; Subcutaneous |
18000000 unit / vial
|
| Powder, for solution | Intramuscular; Subcutaneous |
3000000 unit / vial
|
| Powder, for solution | Intramuscular; Subcutaneous |
9000000 unit / vial
|
| Injection, solution | Subcutaneous |
11.1 ug/0.5mL
|
| Injection, solution | Subcutaneous |
22.2 ug/0.5mL
|
| Injection, solution | Subcutaneous |
33.3 ug/0.5mL
|
| Injection, solution | Subcutaneous |
3000000 IU
|
| Injection, solution | Subcutaneous |
4500000 MIU
|
| Injection, solution | Subcutaneous |
6000000 IU
|
| Injection, solution | Subcutaneous |
9000000 IU
|
| Injection | Intramuscular; Subcutaneous |
3 MIU/0.5ml
|
| Liquid | Intramuscular; Subcutaneous |
3000000 unit / mL
|
| Liquid | Intramuscular; Subcutaneous |
4500000 IU/mL
|
| Solution | Intramuscular; Subcutaneous |
9000000 IU/ml
|
| Solution | Intramuscular; Subcutaneous |
18000000 IU/3mL
|
| Solution | Intramuscular; Subcutaneous |
3 m / mL
|
| Solution | Intramuscular; Subcutaneous |
6000000 IU/mL
|
| Solution | Intramuscular; Subcutaneous |
36000000 unit / mL
|
| Solution | Intramuscular; Subcutaneous |
9000000 unit / .9 mL
|
Target Information